Leap Therapeutics
LPTX
LPTX
19 hedge funds and large institutions have $20.5M invested in Leap Therapeutics in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.38% more ownership
Funds ownership: 0.33% → 1.7% (+1.4%)
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$9.49M | |
| 2 | +$3.54M | |
| 3 | +$1.25M | |
| 4 |
AIC
AWM Investment Company
New York
|
+$802K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$761K |
Top Sellers
| 1 | -$558K | |
| 2 | -$326K | |
| 3 | -$3K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.42K |
| 5 |
BlackRock
New York
|
-$2.18K |